Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome

Background/Purpose: Gastric parietal cell antibody (GPCA), thyroglobulin antibody (TGA), and thyroid microsomal antibody (TMA) are organ-specific autoantibodies. This study mainly assessed the frequencies of serum GPCA, TGA, and TMA positivities in burning mouth syndrome (BMS) patients. Methods: Ser...

Full description

Bibliographic Details
Main Authors: Chun-Pin Chiang, Yang-Che Wu, Yu-Hsueh Wu, Julia Yu-Fong Chang, Yi-Ping Wang, Andy Sun
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664620304095
_version_ 1818400078575960064
author Chun-Pin Chiang
Yang-Che Wu
Yu-Hsueh Wu
Julia Yu-Fong Chang
Yi-Ping Wang
Andy Sun
author_facet Chun-Pin Chiang
Yang-Che Wu
Yu-Hsueh Wu
Julia Yu-Fong Chang
Yi-Ping Wang
Andy Sun
author_sort Chun-Pin Chiang
collection DOAJ
description Background/Purpose: Gastric parietal cell antibody (GPCA), thyroglobulin antibody (TGA), and thyroid microsomal antibody (TMA) are organ-specific autoantibodies. This study mainly assessed the frequencies of serum GPCA, TGA, and TMA positivities in burning mouth syndrome (BMS) patients. Methods: Serum GPCA, TGA, and TMA levels were measured in 884 BMS patients and in 442 age- and sex-matched healthy control subjects. Results: We found that 12.3%, 21.6%, and 22.7% of 884 BMS patients and 1.8%, 2.3%, and 2.9% of 442 healthy control subjects had the serum GPCA, TGA, and TMA positivities, respectively. BMS patients had significantly higher frequencies of GPCA, TGA, and TMA positivities than healthy control subjects (all P-values < 0.001). We also found that 20 (2.3%), 130 (14.7%), and 181 (20.5%) BMS patients and 3 (0.7%), 8 (1.8%), and 6 (1.4%) healthy control subjects had the presence of three (GPCA + TGA + TMA), two (GPCA + TGA, GPCA + TMA, or TGA + TMA), or one (GPCA only, TGA only, or TMA only) organ-specific autoantibody in their sera, respectively. Of 255 TGA/TMA-positive BMS patients whose serum thyroid-stimulating hormone (TSH) levels were measured, 87.8%, 5.1%, and 7.1% of these TGA/TMA-positive BMS patients had normal, lower, and higher serum TSH levels, respectively. Conclusion: Approximately 37.5% of 884 BMS patients have serum GPCA/TGA/TMA positivity. Moreover, 12.3%, 21.6%, and 22.7% of 884 BMS patients have the serum GPCA, TGA, and TMA positivities, respectively. Only 5.1% and 7.1% of TGA/TMA-positive BMS patients have hyperthyroidism and hypothyroidism, respectively. It needs further studies to know whether GPCA-positive BMS patients may finally become as having autoimmune atrophic gastritis.
first_indexed 2024-12-14T07:30:51Z
format Article
id doaj.art-dd03f5d8c4cd40f3827c352bffb56105
institution Directory Open Access Journal
issn 0929-6646
language English
last_indexed 2024-12-14T07:30:51Z
publishDate 2020-12-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj.art-dd03f5d8c4cd40f3827c352bffb561052022-12-21T23:11:22ZengElsevierJournal of the Formosan Medical Association0929-66462020-12-011191217581763Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndromeChun-Pin Chiang0Yang-Che Wu1Yu-Hsueh Wu2Julia Yu-Fong Chang3Yi-Ping Wang4Andy Sun5Department of Dentistry, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; Department of Dentistry, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan; Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan; Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, TaiwanSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan; Department of Dentistry, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City, TaiwanDepartment of Dentistry, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, TaiwanGraduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan; Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan; Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, TaiwanGraduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan; Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan; Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, TaiwanGraduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan; Department of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan; Corresponding author. Department of Dentistry, National Taiwan University Hospital, No. 1, Chang-Te Street, Taipei 10048, Taiwan. Fax: +886 02 2389 3853.Background/Purpose: Gastric parietal cell antibody (GPCA), thyroglobulin antibody (TGA), and thyroid microsomal antibody (TMA) are organ-specific autoantibodies. This study mainly assessed the frequencies of serum GPCA, TGA, and TMA positivities in burning mouth syndrome (BMS) patients. Methods: Serum GPCA, TGA, and TMA levels were measured in 884 BMS patients and in 442 age- and sex-matched healthy control subjects. Results: We found that 12.3%, 21.6%, and 22.7% of 884 BMS patients and 1.8%, 2.3%, and 2.9% of 442 healthy control subjects had the serum GPCA, TGA, and TMA positivities, respectively. BMS patients had significantly higher frequencies of GPCA, TGA, and TMA positivities than healthy control subjects (all P-values < 0.001). We also found that 20 (2.3%), 130 (14.7%), and 181 (20.5%) BMS patients and 3 (0.7%), 8 (1.8%), and 6 (1.4%) healthy control subjects had the presence of three (GPCA + TGA + TMA), two (GPCA + TGA, GPCA + TMA, or TGA + TMA), or one (GPCA only, TGA only, or TMA only) organ-specific autoantibody in their sera, respectively. Of 255 TGA/TMA-positive BMS patients whose serum thyroid-stimulating hormone (TSH) levels were measured, 87.8%, 5.1%, and 7.1% of these TGA/TMA-positive BMS patients had normal, lower, and higher serum TSH levels, respectively. Conclusion: Approximately 37.5% of 884 BMS patients have serum GPCA/TGA/TMA positivity. Moreover, 12.3%, 21.6%, and 22.7% of 884 BMS patients have the serum GPCA, TGA, and TMA positivities, respectively. Only 5.1% and 7.1% of TGA/TMA-positive BMS patients have hyperthyroidism and hypothyroidism, respectively. It needs further studies to know whether GPCA-positive BMS patients may finally become as having autoimmune atrophic gastritis.http://www.sciencedirect.com/science/article/pii/S0929664620304095Burning mouth syndromeGastric parietal cell antibodyThyroglobulin antibodyThyroid microsomal antibody
spellingShingle Chun-Pin Chiang
Yang-Che Wu
Yu-Hsueh Wu
Julia Yu-Fong Chang
Yi-Ping Wang
Andy Sun
Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome
Journal of the Formosan Medical Association
Burning mouth syndrome
Gastric parietal cell antibody
Thyroglobulin antibody
Thyroid microsomal antibody
title Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome
title_full Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome
title_fullStr Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome
title_full_unstemmed Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome
title_short Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome
title_sort gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome
topic Burning mouth syndrome
Gastric parietal cell antibody
Thyroglobulin antibody
Thyroid microsomal antibody
url http://www.sciencedirect.com/science/article/pii/S0929664620304095
work_keys_str_mv AT chunpinchiang gastricparietalcellandthyroidautoantibodiesinpatientswithburningmouthsyndrome
AT yangchewu gastricparietalcellandthyroidautoantibodiesinpatientswithburningmouthsyndrome
AT yuhsuehwu gastricparietalcellandthyroidautoantibodiesinpatientswithburningmouthsyndrome
AT juliayufongchang gastricparietalcellandthyroidautoantibodiesinpatientswithburningmouthsyndrome
AT yipingwang gastricparietalcellandthyroidautoantibodiesinpatientswithburningmouthsyndrome
AT andysun gastricparietalcellandthyroidautoantibodiesinpatientswithburningmouthsyndrome